Literature DB >> 1855984

Phenotypic diversity in the alpha C protein of group B streptococci.

L C Madoff1, S Hori, J L Michel, C J Baker, D L Kasper.   

Abstract

Group B streptococci (GBS) is the leading cause of neonatal sepsis and meningitis. C proteins are an immunologically important group of surface-associated antigens in GBS that remain incompletely characterized. Two C proteins have been designated alpha and beta on the basis of protease susceptibility. We recently used a monoclonal antibody to describe a protective epitope of the GBS alpha (or trypsin-resistant) C protein in the prototype Ia/c GBS strain. In the present study, we examined 51 GBS isolates for expression of C-protein alpha and beta antigens. The alpha antigen, as detected with monoclonal antibody in sodium dodecyl sulfate (SDS) extracts, appears as a heterogeneous series of proteins spaced 8 kDa apart on SDS-polyacrylamide gel electrophoresis, but has a maximum molecular mass that varies among strains from 62.5 to 167 kDa. By immunoblotting with human immunoglobulin A, polyclonal antiserum, or monoclonal antibody, the beta antigen, in contrast, appears as a single protein of molecular mass between 124 and 134 kDa. The amount of alpha antigen expressed by each strain was quantified by enzyme immunoassay inhibition and was found to vary markedly from strain to strain. The susceptibility of strains of GBS to opsonization and killing by human polymorphonuclear leukocytes in the presence of either complement alone or complement with alpha-specific monoclonal antibody was examined. Strains expressing the alpha antigen were less readily killed in the absence of specific antibody than were alpha-negative strains. Killing in the presence of alpha-specific monoclonal antibody was found to correlate directly with the maximum molecular mass of the alpha antigen and with the quantity of antigen on the bacterial cell surface. Isolates of GBS that express the alpha C protein vary widely in the quantity and molecular mass of the alpha antigen produced, and this heterogeneity appears to have biologic importance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1855984      PMCID: PMC258067          DOI: 10.1128/iai.59.8.2638-2644.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

Review 1.  Immunization to prevent group B streptococcal disease: victories and vexations.

Authors:  C J Baker
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

2.  The role of complement and antibody in opsonophagocytosis of type II group B streptococci.

Authors:  C J Baker; B J Webb; D L Kasper; M S Edwards
Journal:  J Infect Dis       Date:  1986-07       Impact factor: 5.226

3.  Group B streptococcal infection in newborns: prevention at last?

Authors:  C J Baker
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

4.  Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes.

Authors:  D R Johnson; P Ferrieri
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

5.  The relation of the Ibc protein antigen to the opsonization differences between strains of type II group B streptococci.

Authors:  N R Payne; P Ferrieri
Journal:  J Infect Dis       Date:  1985-04       Impact factor: 5.226

6.  Ibc proteins as serotype markers of group B streptococci.

Authors:  L Bevanger
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1983-08

7.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

8.  Type-specific capsular antigen is associated with virulence in late-onset group B Streptococcal type III disease.

Authors:  M E Klegerman; K M Boyer; C K Papierniak; L Levine; S P Gotoff
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

9.  Potentiation of virulence by group B streptococcal polysaccharides.

Authors:  N J Levy; A Nicholson-Weller; C J Baker; D L Kasper
Journal:  J Infect Dis       Date:  1984-06       Impact factor: 5.226

10.  Variation in the molecular weight of PspA (pneumococcal surface protein A) among Streptococcus pneumoniae.

Authors:  W D Waltman; L S McDaniel; B M Gray; D E Briles
Journal:  Microb Pathog       Date:  1990-01       Impact factor: 3.738

View more
  33 in total

1.  Mosaicism in the alpha-like protein genes of group B streptococci.

Authors:  C S Lachenauer; R Creti; J L Michel; L C Madoff
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

2.  Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.

Authors:  C Gravekamp; D L Kasper; L C Paoletti; L C Madoff
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Tandem repeat deletion in the alpha C protein of group B streptococcus is recA independent.

Authors:  K M Puopolo; S K Hollingshead; V J Carey; L C Madoff
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.

Authors:  Ravin Seepersaud; Sean B Hanniffy; Peter Mayne; Phil Sizer; Richard Le Page; Jerry M Wells
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  Putative novel surface-exposed Streptococcus agalactiae protein frequently expressed by the group B streptococcus from Zimbabwe.

Authors:  Rooyen T Mavenyengwa; Johan A Maeland; Sylvester R Moyo
Journal:  Clin Vaccine Immunol       Date:  2009-07-08

6.  Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein.

Authors:  V Shankar; A S Baghdayan; M M Huycke; G Lindahl; M S Gilmore
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

7.  Identification of group B streptococcal Sip protein, which elicits cross-protective immunity.

Authors:  B R Brodeur; M Boyer; I Charlebois; J Hamel; F Couture; C R Rioux; D Martin
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

8.  Deletion of repeats in the alpha C protein enhances the pathogenicity of group B streptococci in immune mice.

Authors:  C Gravekamp; B Rosner; L C Madoff
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein.

Authors:  L C Madoff; J L Michel; E W Gong; D E Kling; D L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

10.  Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease.

Authors:  Pia S Pannaraj; Joanna K Kelly; Marcia A Rench; Lawrence C Madoff; Morven S Edwards; Carol J Baker
Journal:  Vaccine       Date:  2007-12-03       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.